YVYuri V. Volokh

Yuri V. Volokh

*This is an algorithmically generated author record based on publicly available information.

Yuri V. Volokh has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neutralizing ability of monoclonal antibodies directed to epitopes of functionally significant Streptococcus pneumoniae pneumolysin domain

    by Ekaterina A. Kurbatova, Irina V. Yakovleva, Natalya F. Gavrilova, Denis S. Vorobyev, Ekaterina E. Petukhova, Irina B. Semenova, Anton E. Zaitsev, Yuri V. Volokh, Nune O. Vartanova, Alexander V. Poddubikov, et al.

    Background. Pneumolysin (Ply) – bacterial cholesterol-dependent cytolysin produced by almost all strains of Streptococcus pneumoniae. Antibodies induced to pneumolysin for some extend are able to neutralize its pathogenic effect on cells.Aim. Investigation of the effect of monoclonal antibodies obtained to native (nPly) and recombinant (rPly) forms of Ply on the neutralization of the cytolytic activity of bacterial Ply in vitro and their preventive properties on mice challenged with a virulent strain of S. pneumoniae.Materials and methods. mAbs to the nPly and rPly forms of Ply was obtained from the ascitic fluid of mice. Polyclonal antibodies pAbs (rPly) were obtained from the serum of rabbits immunized with rPly. The inhibition of erythrocyte hemolysis was assessed by the minimum concentration of mAbs (nPly), pAbs (rPly) and pAbs (rPly), which prevents lysis of erythrocytes induced by nPly. The neutralizing ability of antibodies was evaluated on the ovarian cells of the Chinese hamster CHO-K1 by the minimum concentration of antibodies necessary to protect cells from 4 cytopathogenic doses of nPly. The protective properties of the antibodies were studied with a single intraperitoneal injection of 200 µg of antibodies to mice, followed by challenge with a lethal dose of S. pneumoniae.Results. It was shown that 24 hours after intraperitoneal administration of nPly to mice, the body weight of the animals decreased and degenerative forms of red blood cells appeared in the blood. In in vitro experiments, nPly caused hemolysis of erythrocytes and destruction of CHO-K1 cells by the mechanism of apoptosis. mAbs (nPly), mAbs (rPly) and pAbs (rPly) inhibited erythrocyte hemolysis and neutralized the destruction of CHO-K1 cells. The highest neutralizing activity was shown by mAbs (rPly) and pAbs (rPly). A single injection of the studied antibodies to mice caused a decrease of their death when infected with the S. pneumoniae strain. There were no differences in the protective activity of antibodies.Conclusion. Methods based on neutralizing the toxic effect of Ply S. pneumoniae with the help of antibodies can be considered as a tool to reduce the pathogenicity of pneumococci.


  • Open Access

    Cytopathogenic effect of Streptococcus pneumoniae native pneumolysin in CHO-K1 cells

    by E. A. Kurbatova, I. V. Yakovleva, N. F. Gavrilova, E. S. Petukhova, I. B. Semenova, A. E. Zaitsev, Yu. V. Volokh, A. Yu. Leonova, A. V. Poddubikov

    Background. Streptococcus pneumoniae (S. pneumoniae, pneumococci) is an opportunistic bacterium that causes inflammatory diseases in humans. One of the virulence factors of S. pneumoniae is pneumolysin (Ply), a cholesterol-dependent hemolytic toxin that interacts with cholesterol in eukaryotic cell membranes, forms pores and leads to cell destruction and death.Aim. Immunochemical characteristics of pneumolysin and evaluation of its cytotoxic effect in the culture of Chinese hamster ovarian cells CHO-K1.Materials and methods. To obtain Ply, the S. pneumoniae serotype 3 strain was cultivated in brain heart broth, bacterial cells were pelleted by centrifugation and subjected to ultrasonic disintegration. The presence of pneumolysin in the resulting preparation was confirmed by immunoblotting with monoclonal antibodies to recombinant pneumolysin. The cytopathogenic effect of Ply was studied in a culture of proline-dependent epithelial-like Chinese hamster ovary cells CHO-K1 in RPMI-1640 medium. The hemolytic activity of Ply was assessed in a reaction with mouse erythrocytes.Results. Using ultrasonic disintegration of cells of the S. pneumoniae serotype 3 strain followed by precipitation with ammonium sulfate, a protein that formed a band on electrophoresis at a level corresponding to the molecular weight of Ply (53 kDa) was obtained. The protein possessed the ability to lyse mouse erythrocytes. The authenticity of Ply was confirmed by immunoblotting with monoclonal antibodies to recombinant pneumolysin. Ply had a cytopathogenic effect on Chinese hamster ovary CHO-K1 cells. The minimum dose of the protein that induced a toxic effect on cells, manifested in the appearance of round and small cells along with normal cells, was 16.4 μg/ml per protein. When the concentration was increased up to 65.6 μg/ml, only small round cells were detected. Further increase in concentration resulted in complete destruction of CHO-K1 cells.Conclusion. Pneumolysin can be used to develop new drugs for the treatment of pneumococcal infections.


  • Open Access

    Development of the test system based on enzyme immunoassay for the detection of recombinant Streptococcus pneumoniae pneumolysin

    by E. A. Kurbatova, I. V. Yakovleva, N. F. Gavrilova, D. S. Vorobyev, E. S. Petukhova, I. B. Semenova, A. E. Zaitsev, Yu. V. Volokh, A. Yu. Leonova, A. V. Poddubikov, et al.

    Backgraund. Pneumolysin (Ply) is a hemolytic toxin of Streptococcus pneumoniae (S. pneumoniae) expressed by all strains of pneumococci. The use of sandwich enzyme-linked immunosorbent assay (ELISA) can be a simple, fast and effective way of its qualitative and quantitative determination in biological fluids.Aim. To develop and evaluate the specificity of sandwich ELISA test system for qualitative and quantitative determination of recombinant Ply (rPly) of S. pneumoniae.Materials and methods. Immobilized on the solid phase rabbit’s polyclonal antibodies (pAbs) to rPly were used as recognition antibodies in sandwich ELISA. The studied antigens were added to the pAbs (rPly). The reaction was manifested by using detecting mouse monoclonal IgG1 (rPly) – antibodies conjugated with horseradish root peroxidase. The specificity of the test system was evaluated when using recombinant α-hemolysin (rα-Hly) and water-soluble S. aureus antigens as reference preparations.Results. Using sandwich ELISA, rPly was detected at a concentration of 0.15 µ / ml. The test system was characterized by specificity, which was confirmed by the absence of reaction with recombinant rα-Hly of Staphylococcus aureus (S. aureus). Reference preparations of water-soluble surface antigens of S. aureus strains No 209, 1986,1991 and Cowan I gave a false positive reaction due to the presence of protein A (SpA) in their composition, a thermostable surface protein expressed by many strains of staphylococci capable of binding immunoglobulins via Fc-fragment or Fab fragments of the V3H domain of the B cells receptor. A negative reaction was obtained with antigens from the S. aureus wood 46 strain, which does not have the spa gene encoding SpA expression. The presence of protein A in preparations of water-soluble S. aureus antigens was confirmed in the ELISA inhibition assay.Conclusion. Sandwich ELISA has been developed for qualitative and quantitative determination of S. pneumoniae Ply. The conducted studies have confirmed the specificity of the test system.


  • Open Access

    Serotype-independent protective activity of recombinant pneumolysin in a model of systemic infection caused by Streptococcus pneumoniae serotypes 4 and 6B

    by D. S. Vorobyev, E. S. Petukhova, Yu. V. Volokh, O. М. Afanasyeva, M. M. Tokarskaya, A. Yu. Leonova, O. V. Zhigunova, I. B. Semenova, N. F. Gavrilova, I. V. Yakovleva, et al.

    Background. The development of a pneumococcal vaccine with serotype-independent activity is relevant for the whole world, as this is due to the high prevalence of Streptococcus pneumoniae (S. pneumoniae), the constant change of pathogen serotypes and the growth of antibiotic-resistant strains. In previous experiments, we revealed a protective effect of immunization with recombinant pneumolysin (rPly) in a model of systemic infection caused by S. pneumoniae serotype 3.Aim. Study of serotype-independent protective activity of rPly.Materials and methods. Strains of S. pneumoniae serotypes 4 and 6B were used. Mice were immunized intraperi-toneally two or three times with an interval of 14 days with rPly. To assess the protective activity of rPly, animals after double or triple immunization were infected intraperitoneally with S. pneumoniae .Results. rPly at a triple immunization in a dose of 25 μg protected mice from intraperitoneal infection with S. pneu- moniae serotype 4, the efficiency index increased by 2 times compared with the control. with a double immunization, rPly protected mice from intraperitoneal infection with S. pneumoniae serotype 6B, efficiency index increased by 6.61 times compared with the control.Conclusion. rPly protects animals from infection with different serotypes of S. pneumoniae, which allows us to consider it a promising drug for the development of pneumococcal vaccines with serotype-independent activity.

  • Open Access

    Protective activity of mixtures of pneumococcal antigens in infection caused by Streptococcus pneumoniae serotype 3

    by D. S. Vorobyev, M. M. Tokarskaya, S. A. Baranovskaya, E. A. Stefutushkina, O. M. Afanasyeva, E. A. Astashkina, O. V. Zhigunova, Yu. V. Volokh, A. Yu. Leonova, E. S. Petukhova, et al.

    Introduction. Pneumococcal diseases remain relevant for the whole world. On the one hand, this is due to the high prevalence of pneumococcus and the other hand, the growth of antibiotic-resistant strains and the constant change of clinically significant serotypes of the pathogen.The aim of the research was to study of the protective activity of a mixture of pneumococcal antigens.Material and methods. we used preparations of a capsular polysaccharide (CPS) obtained from Streptococcus pneumoniae serotype 3; protein-containing fraction (PCF) obtained from an aqueous extract of cells of S. pneumoniae serotype 6B; recombinant pneumolysin (rPly). Mice were immunized intraperitoneally twice with an interval of 14 days with mixtures of bacterial antigens: CPS + PCF; CPS + rPly; PCF + rPly. To assess the protective activity of the studied drugs after double immunization animals were infected intraperitoneally with S. pneumoniae serotype 3. To study the effect of mixtures of bacterial preparations on the infectious process in the lungs immunized mice were infected with S. pneumoniae serotype 3. The humoral immune response was studied with IgG using the method of ELISA.Results. The CPS + rPly mixture protected mice from intraperitoneal infection with S. pneumoniae serotype 3 regardless of the infecting dose. Immunization with CPS + PCF or CPS + rPly mixtures influenced a significant decrease the number of seeded bacterial cells from lungs during the entire observation period (72 h) compared to the control. Administration of mixtures of bacterial antigens of CPS + PCF, CPS + rPly or PCF + rPly to animals led to a significant increase of the level of antibodies to all antigens, however, the highest levels of IgG were determined to PCF and rPly.Conclusion. The results obtained suggest that different antigenic drugs in mixtures affect different mechanisms of immunity activation.